臨床試驗

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

NCT：NCT04796350 · RECRUITING

NCT IDNCT04796350

狀態RECRUITING

開始日期2021-04-24

完成時間2029-04-01

SponsorAgNovos Healthcare, LLC (INDUSTRY)

First posted2021-03-12

Last updated2026-05-13

簡要摘要

A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。